Bill Facteau insider trades
Open-market stock purchases and sales by Bill Facteau, Director at BioCardia, Inc, from SEC Form 4 filings since Oct 18, 2023.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -51%.
Companies traded
- BCDA BioCardia, Inc: 1 buy, last Jul 6, 2026
- BCDA;BCDAW BioCardia, Inc: other filings, last Oct 18, 2023